Long-term Management of CKD–Mineral and Bone Disorder
American Journal of Kidney Diseases,  Clinical Article

Martin KJ et al. – The heterogeneity of Chronic kidney disease–mineral and bone disorder (CKD–MBD) makes strict protocol–driven therapeutic approaches difficult; accordingly, considerable individualized therapy is required. Using a case history, the authors explore several of the variables and difficulties involved in patient management.

  • Chronic kidney disease–mineral and bone disorder (CKD–MBD) is the term used to describe the abnormalities of bone and mineral metabolism that occur in the setting of kidney disease.
  • The spectrum of these abnormalities is wide, ranging from severe high–turnover bone disease on one end to marked low bone turnover bone disease on the other.
  • Similarly, some patients have severe vascular calcifications while others do not, and the values for biochemistry determinations, including calcium, phosphorus, and parathyroid hormone, also may vary widely among patients.
  • This variability may be influenced by such things as the chronicity of the particular kidney disease, effects of therapies such as corticosteroids on modifying the course of kidney disease, and comorbid conditions, such as diabetes, heart disease, age, and osteoporosis.

Please login or register to follow this author.
► Click here to access PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Nephrology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Nephrology Articles

1 New version of common antibiotic could eliminate risk of hearing loss, study finds Stanford School of Medicine News, January 6, 2015

2 Study: Investigational drug reduces high potassium levels in chronic kidney disease patients University of Maryland Medical Center News, November 25, 2014

3 Treatment of metabolic acidosis in patients with stage 3 chronic kidney disease with fruits and vegetables or oral bicarbonate reduces urine angiotensinogen and preserves glomerular filtration rate Kidney International, April 3, 2014    Clinical Article
Exclusive Author Commentary

4 Intravenous magnesium sulfate: new method in prevention of contrast-induced nephropathy in primary percutaneous coronary intervention International Urology and Nephrology, December 8, 2014    Clinical Article

5 Sodium zirconium cyclosilicate in hyperkalemia New England Journal of Medicine, November 26, 2014    Evidence Based Medicine    Clinical Article

6 Dialysis for undocumented immigrants in the United States Advances In Chronic Kidney Disease , January 12, 2015    Clinical Article

7 A randomized comparison of 1-h sodium bicarbonate hydration versus standard peri-procedural saline hydration in patients with chronic kidney disease undergoing intravenous contrast-enhanced computerized tomography Nephrology Dialysis Transplantation, May 5, 2014    Clinical Article

8 Mortality risk of darbepoetin alfa versus epoetin alfa in patients with CKD: Systematic review and meta-analysis American Journal of Kidney Diseases, January 29, 2015    Evidence Based Medicine    Review Article

9 Effects of tea intake on blood pressure: A meta-analysis of 21 randomized controlled trials JACC - Journal of the American College of Cardiology, October 22, 2014    Clinical Article

10 Tonsillectomy for IgA nephropathy: A meta-analysis American Journal of Kidney Diseases, October 29, 2014    Evidence Based Medicine

11 Effects of intensive blood pressure lowering on the progression of chronic kidney disease: a systematic review and meta-analysis Canadian Medical Association Journal, August 12, 2013    Evidence Based Medicine    Review Article    Clinical Article

12 Associations of sugar and artificially sweetened soda and chronic kidney disease: A systematic review and meta-analysis Nephrology, September 26, 2014    Evidence Based Medicine    Review Article

13 Screening and treatment for Staphylococcus aureus in patients undergoing hemodialysis: A systematic review and meta-analysis Full Text BMC Nephrology, December 19, 2014    Free full text    Evidence Based Medicine    Review Article

14 Extra-renal manifestations of autosomal dominant polycystic kidney disease (ADPKD): Considerations for routine screening and management Nephrology Dialysis Transplantation, February 6, 2014    Review Article

15 Medications associated with restless legs syndrome: a case–control study in the US Renal Data System (USRDS) Sleep Medicine, October 8, 2014    Clinical Article

16 Metformin in chronic kidney disease: Time for a rethink Peritoneal Dialysis International, July 9, 2014    Clinical Article

17 Effect of l-carnitine therapy on patients in maintenance hemodialysis: A systematic review and meta-analysis Full Text Journal of Nephrology, May 14, 2014    Free full text    Evidence Based Medicine    Review Article

18 The effect of continuous versus intermittent renal replacement therapy on the outcome of critically ill patients with acute renal failure (CONVINT): A prospective randomized controlled trial Critical Care, January 13, 2014    Clinical Article

19 Chlorthalidone for poorly controlled hypertension in chronic kidney disease: An interventional pilot study American Journal of Nephrology, February 12, 2014    Clinical Article

20 Short course daily prednisolone therapy during an upper respiratory tract infection in children with relapsing steroid-sensitive nephrotic syndrome (PREDNOS 2): protocol for a randomised controlled trial Full Text Trials, May 1, 2014    Free full text    Evidence Based Medicine    Clinical Article

Indexed Journals in Nephrology: Kidney International, Hemodialysis International, Nephrology Dialysis Transplantationmore

Looking for a physician job? Let us help!

Register now for our free job placement service.
A career consultant will contact you soon.
Click Here for more information.

Get Started Now!

Free-of-charge, no obligation.

Terms and Conditions For M3 Career Consult

By registering with the M3 Career Consult service you authorize M3 USA Corporation to represent you in your job search. The following is a summary of the terms of our service and our mutual obligations to help you find a job:

  • You designate M3 to act as your agent and represent you in your job search;
  • You will not pay us for this service
  • You will advise us of any companies or positions to which you apply or have applied;
  • You will advise us if you believe you are not capable of performing a position for which we submit you, or for which you interview;
  • You will keep all information we provide you about companies or positions strictly confidential;
  • You will promptly provide us with information we request of you;
  • You will make yourself reasonably available for phone, video and in-person conversations and interviews;
  • You will be truthful in all of your communications with us; and
  • You will advise us if anything above changes.
 

The Top Read Articles of 2014 are Now Available

Scouring thousands of peer-reviewed journals and popular press, Our Editors just released the Top Read Articles of the Year. See the Top Read List